Planned for CCRT and adjuvant immunotherapy (intention to treat)
Primary tumour volume outside of mediastinal PRV (i.e., mediastinal envelope + 5 mm) ≥60% of total primary tumour volume (true for 75% of patients in preliminary analysis), for sufficient dose escalation
You may not be if
Chemotherapy not given concurrently with radiotherapy
Upfront decision that adjuvant immunotherapy is not possible
Primary tumour overlapping ≥40% with mediastinal PRV
Unable or unwilling to understand the information on trial-related topics, to give informed consent or to fill out quality-of-life questionnaires
